5-1279370-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM1PP5BP4
The NM_198253.3(TERT):c.2051A>G(p.Asp684Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000715 in 1,567,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D684N) has been classified as Uncertain significance.
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Publications
- pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- dyskeratosis congenita, autosomal dominant 2Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
- acute myeloid leukemiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- dyskeratosis congenitaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hoyeraal-Hreidarsson syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- melanoma, cutaneous malignant, susceptibility to, 9Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.2051A>G | p.Asp684Gly | missense_variant | Exon 5 of 16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.2051A>G | p.Asp684Gly | missense_variant | Exon 5 of 15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.2130A>G | non_coding_transcript_exon_variant | Exon 5 of 13 | ||||
TERT | NR_149163.3 | n.2130A>G | non_coding_transcript_exon_variant | Exon 5 of 13 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152094Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000158 AC: 27AN: 170622 AF XY: 0.000162 show subpopulations
GnomAD4 exome AF: 0.0000664 AC: 94AN: 1415304Hom.: 0 Cov.: 33 AF XY: 0.0000686 AC XY: 48AN XY: 700184 show subpopulations
GnomAD4 genome AF: 0.000118 AC: 18AN: 152094Hom.: 0 Cov.: 34 AF XY: 0.000202 AC XY: 15AN XY: 74298 show subpopulations
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal dominant 2;C3553617:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 Pathogenic:1
- -
Dyskeratosis congenita Pathogenic:1
Variant summary: TERT c.2051A>G (p.Asp684Gly) results in a non-conservative amino acid change located in the Reverse transcriptase domain (IPR000477) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.1e-05 in 1567398 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TERT causing Dyskeratosis congenita, however the frequency in the Finnish subpopulation was 0.0018 in 59326 control chromosomes. These data allow no conclusion about variant significance but may suggest a possible founder effect among individuals of Finnish descent. c.2051A>G has been reported in the literature in the compound heterozygous or homozygous state in multiple Finnish/Nordic individuals affected with clinical features of Dyskeratosis congenita and related telomere biology disorders (example, Norberg_2018, Trotta_2018) and in the heterozygous state in multiple individuals with familial pulmonary fibrosis and/or interstitial lung disease (example, Liu_2023, Stark_2022). These data indicate that the variant is very likely to be associated with autosomal recessive disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36622818, 29483670, 35083318, 30115091). ClinVar contains an entry for this variant (Variation ID: 446372). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 684 of the TERT protein (p.Asp684Gly). This variant is present in population databases (rs776981958, gnomAD 0.1%). This missense change has been observed in individual(s) with TERT-related conditions (PMID: 29483670). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 446372). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TERT protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at